Although uterine fibroids are often asymptomatic, in some women they can cause symptoms such as heavy menstrual bleeding—a problem that may be impacting your patients more than you realize. This interactive video lecture uses expert discussions and case examples to illustrate when to look for symptoms, how to talk about them with patients, and what choices are available for management.
Interactive video lecture
After completing this activity, participants should be better able to:
- Assess patients for risk factors and symptoms of uterine fibroids to help enable appropriate diagnosis and management
- Describe the risks and benefits of current and emerging medical therapies used in the treatment of uterine fibroids
- Formulate personalized treatment strategies for uterine fibroids and associated heavy menstrual bleeding based on efficacy, safety, and patient- and tumor-related factors
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP Course Advisor: Susan Tiso, DNP, FNP-BC, University of California, Irvine, Irvine, California
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 30, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Jennifer Wohl, DHSc, PA-C of Eastern Virginia Medical School, Norfolk, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program was cosupported by educational grants from AbbVie Inc.; Amgen; Genentech, a member of the Roche Group; Incyte; and Merck.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Herman: fees for non-CE/CME services: Novo Nordisk.
Dr Tu: consulting fees: AbbVie, Myovant, UroShape; fees for non-CME/CE services: AbbVie.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: August 31, 2021
Expiration date: August 30, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102121C-7A